Innovative Research Award

Vijay Mohan
Galgotias University

Vijay Mohan is associated with Galgotias University, India, and is engaged in research related to Cancer Drug Discovery. His academic work focuses on scientific approaches that contribute to understanding therapeutic targets, drug development strategies, and translational biomedical research. Through scholarly publications and research dissemination, he has contributed to the growing body of knowledge supporting advancements in oncology and pharmaceutical sciences.[1]

Abstract

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful scholarly contributions. Vijay Mohan’s research profile reflects engagement in Cancer Drug Discovery, a field that integrates biomedical science, medicinal chemistry, pharmacology, and computational approaches to identify and develop effective therapeutic interventions. His publication and citation record illustrates active participation in scientific inquiry and knowledge dissemination within the biomedical research community.[1][2]

Keywords

Cancer Drug Discovery; Oncology Research; Therapeutic Development; Pharmaceutical Sciences; Biomedical Innovation; Precision Medicine; Drug Design; Translational Research; Cancer Therapeutics; Innovative Research.

Introduction

Cancer remains one of the most significant global health challenges, creating an ongoing need for innovative therapeutic strategies and improved treatment approaches. Cancer Drug Discovery encompasses multidisciplinary efforts directed toward identifying novel compounds, therapeutic targets, and personalized treatment methodologies. Researchers working in this field contribute to advancements that support both fundamental scientific understanding and practical clinical applications.[2]

Research Profile

Vijay Mohan is affiliated with Galgotias University and has established a documented research presence within Cancer Drug Discovery. According to available scholarly indicators, his profile includes two indexed publications, twenty-three citations, and an h-index of two. These metrics reflect research visibility and participation in academic discourse within biomedical and pharmaceutical research domains.[1]

• Research focus on cancer therapeutics and drug discovery.
• Interest in translational and biomedical research methodologies.
• Contribution to scientific publication and scholarly communication.
• Participation in interdisciplinary healthcare research initiatives.

Research Contributions

Research contributions within Cancer Drug Discovery support the identification of novel therapeutic compounds and improve understanding of disease mechanisms. Scientific efforts in this area often involve target validation, medicinal chemistry, molecular biology, and pharmacological evaluation. Such contributions assist in the development of more effective and personalized treatment strategies for cancer patients.[2]

• Investigation of therapeutic targets relevant to oncology.
• Support for innovative approaches to drug development.
• Contribution to evidence-based biomedical research.
• Participation in scientific initiatives focused on healthcare advancement.

Publications

The publication record associated with Vijay Mohan reflects scholarly engagement within biomedical and pharmaceutical research. Publications serve as an important mechanism for communicating scientific findings, facilitating peer review, and supporting future investigations in cancer-related research fields.[1]

1. Research publications related to cancer therapeutics.
2. Scientific articles supporting drug discovery initiatives.
3. Peer-reviewed contributions to biomedical literature.
4. Collaborative research outputs within healthcare sciences.

Research Impact

Research impact may be evaluated through scholarly publications, citations, academic visibility, and contribution to scientific advancement. The citation record associated with Vijay Mohan indicates engagement with the research community and demonstrates that his work has contributed to ongoing scientific discussions within cancer-related biomedical research.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific relevance, and meaningful academic contribution. Based on available research indicators and documented scientific engagement, Vijay Mohan exhibits characteristics aligned with innovative research practice through his involvement in Cancer Drug Discovery and biomedical research initiatives. These attributes support consideration within research recognition and excellence programs.[1]

Conclusion

Vijay Mohan’s research profile reflects continued engagement in Cancer Drug Discovery and biomedical research. Through scholarly publication, scientific communication, and contributions to oncology-related investigations, he participates in efforts aimed at advancing therapeutic innovation and healthcare outcomes. The Innovative Research Award provides an appropriate framework for recognizing such scholarly contributions and encouraging continued research excellence.[1]

External Links

• Scopus Author Profile

References

1. Elsevier. (n.d.). Scopus author details: Vijay Mohan, Author ID 57472028500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57472028500
2. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
   https://www.mdpi.com/2072-6694/15/14/3685